共 50 条
- [1] More on Eculizumab for Congenital Atypical Hemolytic-Uremic Syndrome Reply [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (20): : 2143 - 2143
- [2] Eculizumab for Congenital Atypical Hemolytic-Uremic Syndrome. [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (05): : 544 - 546
- [3] Eculizumab in Atypical Hemolytic-Uremic Syndrome [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (14): : 1377 - 1378
- [4] Eculizumab in Atypical Hemolytic-Uremic Syndrome Reply [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (14): : 1379 - 1380
- [5] Eculizumab for Atypical Hemolytic-Uremic Syndrome. [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (05): : 542 - 544
- [6] Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic-Uremic Syndrome [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (23): : 2169 - 2181
- [7] Gemcitabine-Associated Atypical Hemolytic-Uremic Syndrome Treated with Eculizumab [J]. CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2020, 73 (01): : 77 - 78
- [9] Atypical hemolytic-uremic syndrome due to scleroderma renal crisis treated with eculizumab [J]. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2023, 133 (02):